Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02131324

Public ClinicalTrials.gov record NCT02131324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption With DFD-06 Cream Versus Clobetasol Propionate Cream, 0.05% in Subjects With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT02131324
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Promius Pharma, LLC
Industry
Enrollment
50 participants

Conditions and interventions

Conditions

Interventions

  • DFD06 Cream Drug
  • Clobetasol Propionate Cream 0.05% Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2014
Primary completion
Mar 31, 2016
Completion
Aug 10, 2016
Last update posted
May 17, 2018

2014 – 2016

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Advanced Research Associates Glendale Arizona 85308
Agave Clinical Research, LLC Mesa Arizona 85202
T. Joseph Raoof, MD, Inc. Encino California 91436
International Dermatology Research, Inc. Miami Florida 33144
FXM Research Corp. Miami Florida 33175
FXM Research Miramar Miramar Florida 33027
Belleair Research Pinellas Park Florida 33781
Forward Clinical Trials Tampa Florida 33624
Marietta Dermatology Clinical Research, Inc. Marietta Georgia 30060
Determatology Specialists Research, LLC Louisville Kentucky 40202
Quality Clinical Research, Inc. Omaha Nebraska 68114
Dermatology Consulting Services High Point North Carolina 27262
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Clinical Partners, LLC Johnston Rhode Island 02919
Radiant Research, Inc. Greer South Carolina 29650

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02131324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02131324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →